Google Alert - lose weight

	lose weight As-it-happens update ⋅ May 13, 2026
	NEWS
	The evolving landscape of obesity pharmacotherapy | Nature Reviews Drug Discovery Nature ... weight loss of more than 20% in humans and improvements in a broad range of obesity-related comorbidities. In this Review, we trace the recent ... Flag as irrelevant
	New daily pill may help people keep weight off after stopping jabs | The Independent The Independent Orforglipron works by lowering blood sugar levels, slowing food digestion and reducing appetite. Flag as irrelevant
	People who have lost weight using tirzepatide are seven times more likely to maintain their ... FirstWord Pharma Those who used the lower dose of 5mg tirzepatide to maintain weight loss are four times more likely to do so than those taking placeboNew research ... Flag as irrelevant
	By ending the struggle to shed pounds, the weight-loss revolution rings hollow The Telegraph The satisfaction that came with becoming slimmer was never simply about the outcome but also the journey. Effortless jabs change this. Flag as irrelevant
	Weight Loss Maintained With Low-Dose Tirzepatide, Orforglipron - Endocrinology Advisor Endocrinology Advisor Topline data were announced from two phase 3b trials evaluating weight loss maintenance with Foundayo or low dose Zepbound after initial treatment ... Flag as irrelevant
	New obesity drug outperformed today's leading injections - Earth.com Earth.com Scientists developed a five-target obesity drug that outperformed Ozempic in weight loss and blood sugar control in obese mice. Flag as irrelevant
	expert reaction to an RCT on the use of pasteurized Akkermansia muciniphila MucT for ... Science Media Centre A randomised controlled trial published in Nature Medicine looks at pasteurized Akkermansia muciniphila MucT for weight loss maintenance in people ... Flag as irrelevant
	It was analyzed that high-dose products from the stomach show an effect on weight loss, but ... mk.co.kr The focus of this clinical trial is on the weight loss level that appears when a 7.2mg high dose is administered. According to Novo Nordisk, the Early ... Flag as irrelevant
	Study shows use of obesity drugs alongside behavioral intervention is associated ... - Medical Xpress Medical Xpress The authors say, "Food noise was reduced during weight loss treatment, and initiation of GLP-1 RA drugs was associated with a significantly greater ... Flag as irrelevant
	MinuteClinic highlights access and outcomes in clinically supervised weight-loss program PR Newswire PRNewswire/ -- As chronic conditions tied to metabolic health continue to rise across the United States, MinuteClinic®, the medical clinic inside ... Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback